Like every year bbi-biotech sent a small team to interphex 2017 in New York to strengthen our networks on the other side of the Atlantic, have discussions with clients and suppliers and present our automated and sterile sampling system bioPROBE.
In an interview with the editor of the Pharma’s Almanac on the topic Better Data in Bioprocessing bbi’s CEO Bernd-Ulrich Wilhelm talks about the motivation for the development of bioPROBE, the chances of the FDA PAT initiative for bbi-biotech and the general market environment.
Video Player
00:00
05:17
The interview was conducted in a Tesla Modell X, that attracted the attention of the visitors not only with its bright colors – a suitable place to advertise the automation capabilities of bbi-biotech.
In summary, the visit to interphex was a complete success – we were able to have many crucial discussions that will strengthen our position in the North American market. and hand out all the marketing material we brought to New York.Next year we will probably have to bring along a few hundred more flyers.Interview on Pharma’s Almanac
